Hospira Logo (Bleomycin 01)
Bleomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 61703-332
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 61703-332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula Bleomycin (Bleomycin 02)
Hospira Logo (Bleomycin 03)
Principal Display Panel (15 unit Vial Label)
Not available.*
Carton Ndc 61703-332-18 (Bleomycin 05)
This text appears to be information provided with a medication called Bleomycin for injection. The medication is used for intravenous, intramuscular, subcutaneous, and ntrapleural use. The text provides information about the dosage and handling procedures for this medication. The vial contains 30 units of Bleomycin Sulfate and must be stored under refrigeration. It is important to dispose of any unused portions according to the instructions. The text also has a warning that this medication is cytotoxic and special handling procedures must be followed.*
Principal Display Panel (30 unit Vial Label)
Carton Ndc 61703-323-22 (Bleomycin 07)
This is a cautionary message regarding a Cytotoxic drug, Bleomycin Sulfate, for Injection. The dosage, indications, and handling procedures are provided in the enclosed package insert. The drug is distributed by Hospira Inc. and must be stored under refrigeration at 2°C to 8°C. The drug is for intravenous, intramuscular, subcutaneous, and intrapleural use only with a single-use vial containing 15 units of Bleomycin Sulfate.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
